JL0 · 3-[13-methyl-5,7,12,14-tetrakis(oxidanylidene)-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]propyl 3-[5,7,12,14-tetrakis(oxidanylidene)-13-(3-oxidanylpropyl)-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1,3,8(16),9,11(15)-pentaen-6-yl]propyl hydrogen phosphate

Binding sites

JL0 in 2 structures; the first of them:

• 7ZKL · X-ray structure of the complex between human alpha thrombin and a pseudo-cyclic thrombin… · JL0 A101 · binds DG1, DG6, DT7, DG8, DG10, DG15
• 7ZKM · X-ray structure of the complex between human alpha thrombin and a pseudo-cyclic thrombin… · JL0 A101 · binds DG1, DG6, DG10, DG15

Residues it binds most

DG 3, DT 2 (residue and the binding sites it lines).

Found with

• 0G6 · D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide
• JKR · 3-[5-[3-bis(oxidanyl)phosphanyloxypropoxy]naphthalen-1-yl]oxypropyl 3-(5-oxidanylnaphthalen-1-yl)oxypropyl hydrogen phosphate
• K · Potassium ion
• NA · Sodium ion
• LMR · (2S)-2-hydroxybutanedioic acid
• NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose